|
Status |
Public on May 18, 2023 |
Title |
Neoantigen-Specific CD8 T Cells with High Structural Avidity Preferentially Reside in and Eliminate Tumors |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing Other
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
Web link |
https://pubmed.ncbi.nlm.nih.gov/37280206/
|
|
|
Citation(s) |
37280206 |
Submission date |
May 12, 2023 |
Last update date |
Aug 17, 2023 |
Contact name |
David Barras |
E-mail(s) |
david.barras@chuv.ch
|
Organization name |
Centre hospitalier universitaire vaudois
|
Department |
Oncology
|
Street address |
AGORA, Bugnon 25A
|
City |
Lausanne |
State/province |
Vaud |
ZIP/Postal code |
1005 |
Country |
Switzerland |
|
|
Platforms (1) |
GPL20301 |
Illumina HiSeq 4000 (Homo sapiens) |
|
Samples (8)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE232444 |
Neoantigen-Specific CD8 T Cells with High Structural Avidity Preferentially Reside in and Eliminate Tumors (GEX) |
GSE232446 |
Neoantigen-Specific CD8 T Cells with High Structural Avidity Preferentially Reside in and Eliminate Tumors (VDJ) |
|
Relations |
BioProject |
PRJNA971992 |